Go to
JCI Insight
Citations to this article
Olurotimi O. Mesubi, … , Natasha E. Zachara, Mark E. Anderson
Published November 5, 2020
Citation Information: J Clin Invest. 2021;131(2):e95747. https://doi.org/10.1172/JCI95747.
Citation Information: J Clin Invest. 2021;131(2):e95747. https://doi.org/10.1172/JCI95747.
Abstract
Diabetes mellitus (DM) and atrial fibrillation (AF) are major unsolved public health problems, and diabetes is an independent risk factor for AF. However, the mechanism(s) underlying this clinical association is unknown. ROS and protein O-GlcNAcylation (OGN) are increased in diabetic hearts, and calmodulin kinase II (CaMKII) is a proarrhythmic signal that may be activated by ROS (oxidized CaMKII, ox-CaMKII) and OGN (OGN-CaMKII). We induced type 1 (T1D) and type 2 DM (T2D) in a portfolio of genetic mouse models capable of dissecting the role of ROS and OGN at CaMKII and global OGN in diabetic AF. Here, we showed that T1D and T2D significantly increased AF, and this increase required CaMKII and OGN. T1D and T2D both required ox-CaMKII to increase AF; however, we did not detect OGN-CaMKII or a role for OGN-CaMKII in diabetic AF. Collectively, our data affirm CaMKII as a critical proarrhythmic signal in diabetic AF and suggest ROS primarily promotes AF by ox-CaMKII, while OGN promotes AF by a CaMKII-independent mechanism(s). These results provide insights into the mechanisms for increased AF in DM and suggest potential benefits for future CaMKII and OGN targeted therapies.
Authors
Olurotimi O. Mesubi, Adam G. Rokita, Neha Abrol, Yuejin Wu, Biyi Chen, Qinchuan Wang, Jonathan M. Granger, Anthony Tucker-Bartley, Elizabeth D. Luczak, Kevin R. Murphy, Priya Umapathi, Partha S. Banerjee, Tatiana N. Boronina, Robert N. Cole, Lars S. Maier, Xander H. Wehrens, Joel L. Pomerantz, Long-Sheng Song, Rexford S. Ahima, Gerald W. Hart, Natasha E. Zachara, Mark E. Anderson
Citation information
Citations to this article (39)
| Title and authors | Publication | Year |
|---|---|---|
|
Macrophage-mediated interleukin-6 signaling drives ryanodine receptor-2 calcium leak in postoperative atrial fibrillation
Joshua A. Keefe, Yuriana Aguilar-Sanchez, Jose Alberto Navarro-Garcia, Isabelle Ong, Luge Li, Amelie Paasche, Issam Abu-Taha, Marcel A. Tekook, Florian Bruns, Shuai Zhao, Markus Kamler, Ying H. Shen, Mihail G. Chelu, Li Na, Dobromir Dobrev, Xander H. T. Wehrens |
Journal of Clinical Investigation | 2025 |
|
Macrophage interleukin-1β mediates atrial fibrillation risk in diabetic mice
Xiaoxu Zhou, Hong Liu, Feng Feng, Gyeoung-Jin Kang, Man Liu, Samuel C. Dudley Jr. |
JCI Insight | 2024 |
|
Prostaglandin I2 signaling prevents angiotensin II-induced atrial remodeling and vulnerability to atrial fibrillation in mice
Yue Zhang, Meng Yuan, Wenbin Cai, Weiyan Sun, Xuelian Shi, Daiqi Liu, Wenhua Song, Yingqun Yan, Tienan Chen, Qiankun Bao, Bangying Zhang, Tong Liu, Yi Zhu, Xu Zhang, Guangping Li |
Cellular and molecular life sciences : CMLS | 2024 |
|
Modulation of NOX2 causes obesity-mediated atrial fibrillation
Arvind Sridhar, Jaime UIC, Mahmud A. Pavel, Hanna Chen, Olivia Ly, Asia Owais, Miles Barney, Jordan Jousma, Sarath Nukala, Khaled Abdelhady, Malek Massad, Lona E. Rizkallah, Sang-Ging Ong, Jalees Rehman, Dawood DARBAR |
Journal of Clinical Investigation | 2024 |
|
Zbtb16 increases susceptibility of atrial fibrillation in type 2 diabetic mice via Txnip-Trx2 signaling
Wei ZX, Cai XX, Fei YD, Wang Q, Hu XL, Li C, Hou JW, Yang YL, Chen TZ, Xu XL, Wang YP, Li YG |
Cellular and Molecular Life Sciences | 2024 |
|
The multifaceted role of intracellular glycosylation in cytoprotection and heart disease.
Umapathi P, Aggarwal A, Zahra F, Narayanan B, Zachara NE |
The Journal of biological chemistry | 2024 |
|
Roles of O-GlcNAcylation in Mitochondrial Homeostasis and Cardiovascular Diseases.
Qiu Z, Cui J, Huang Q, Qi B, Xia Z |
2024 | |
|
Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications.
Bode D, Pronto JRD, Schiattarella GG, Voigt N |
Nature reviews. Cardiology | 2024 |
|
Loss of Cardiac PFKFB2 Drives Metabolic, Functional, and Electrophysiological Remodeling in the Heart
Harold KM, Matsuzaki S, Pranay A, Loveland BL, Batushansky A, Mendez Garcia MF, Eyster C, Stavrakis S, Chiao YA, Kinter M, Humphries KM |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2024 |
|
Calpain inhibition takes center stage against atrial fibrillation in the diabetic heart
Ríos-Pérez EB, Alvarado FJ |
Heart rhythm : the official journal of the Heart Rhythm Society | 2024 |
|
Cell-cell communication: new insights and clinical implications.
Su J, Song Y, Zhu Z, Huang X, Fan J, Qiao J, Mao F |
Signal Transduction and Targeted Therapy | 2024 |
|
SGLT2 inhibitors protect against diabetic cardiomyopathy and atrial fibrillation through a CaMKII independent mechanism
Severino A, Reyes-Gaido OE, Nguyen P, Elkarim A, Luczak ED, Mesubi OO |
bioRxiv | 2024 |
|
Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy
Papanicolaou KN, Jung J, Ashok D, Zhang W, Modaressanavi A, Avila E, Foster DB, Zachara NE, O'Rourke B |
The Journal of biological chemistry | 2023 |
|
Identification and validation of key genes associated with atrial fibrillation in the elderly
Liu C, Zeng J, Wu J, Wang J, Wang X, Yao M, Zhang M, Fan J |
Frontiers in Cardiovascular Medicine | 2023 |
|
NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation
Ramos-Mondragón R, Lozhkin A, Vendrov AE, Runge MS, Isom LL, Madamanchi NR |
Antioxidants | 2023 |
|
Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity
Narayanan B, Sinha P, Henry R, Reeves RA, Paolocci N, Kohr MJ, Zachara NE |
The Journal of biological chemistry | 2023 |
|
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor
Gaido OE, Pavlaki N, Granger JM, Mesubi OO, Liu B, Lin BL, Long A, Walker D, Mayourian J, Schole KL, Terrillion CE, Nkashama LJ, Hulsurkar MM, Dorn LE, Ferrero KM, Huganir RL, Müller FU, Wehrens XH, Liu JO, Luczak ED, Bezzerides VJ, Anderson ME |
Science Translational Medicine | 2023 |
|
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
|
Circulation | 2023 |
|
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar J, Chung M, Armbruster A, Benjamin E, Chyou J, Cronin E, Deswal A, Eckhardt L, Goldberger Z, Gopinathannair R, Gorenek B, Hess P, Hlatky M, Hogan G, Ibeh C, Indik J, Kido K, Kusumoto F, Link M, Linta K, Marcus G, McCarthy P, Patel N, Patton K, Perez M, Piccini J, Russo A, Sanders P, Streur M, Thomas K, Times S, Tisdale J, Valente A, Van Wagoner D |
Journal of the American College of Cardiology | 2023 |
|
Dendritic cell immunoreceptor drives atopic dermatitis by modulating oxidized CaMKII-involved mast cell activation
Xiaoyan Luo, Jingsi Chen, Huan Yang, Xinyue Hu, Martin P Alphonse, Yingchun Shen, Yuko Kawakami, Xiaoying Zhou, Wei Tu, Toshiaki Kawakami, Mei Wan, Nathan K. Archer, Hua Wang, Peisong Gao |
JCI Insight | 2022 |
|
Ca2+ mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy
CJ Giusti, J Palomeque, A Mattiazzi |
Pflügers Archiv - European Journal of Physiology | 2022 |
|
Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by RIPK3 Alleviates Necroptosis in Transverse Arch Constriction-Induced Heart Failure
J Cao, J Zhang, J Qian, X Wang, W Zhang, X Chen |
Frontiers in Cardiovascular Medicine | 2022 |
|
O-GlcNAcylation in Renal (Patho)Physiology
Silva-Aguiar RP, Peruchetti DB, Pinheiro AA, Caruso-Neves C, Dias WB |
International journal of molecular sciences | 2022 |
|
Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice.
Ni L, Lahiri SK, Nie J, Pan X, Abu-Taha I, Reynolds JO, Campbell HM, Wang H, Kamler M, Schmitz W, Müller FU, Li N, Wei X, Wang DW, Dobrev D, Wehrens XHT |
Cardiovascular Research | 2022 |
|
The dual role of the hexosamine biosynthetic pathway in cardiac physiology and pathophysiology
Cairns M, Joseph D, Essop MF |
Frontiers in Endocrinology | 2022 |
|
Oxidative stress–induced autonomous activation of the calcium/calmodulin-dependent kinase II involves disulfide formation in the regulatory domain
Rocco-Machado N, Lai L, Kim G, He Y, Luczak ED, Anderson ME, Levine RL |
The Journal of biological chemistry | 2022 |
|
Integration of O-GlcNAc into Stress Response Pathways
Fahie KM, Papanicolaou KN, Zachara NE |
Cells | 2022 |
|
Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice.
Mikhailov AV, Liu Y, Cheng HJ, Lin JJ, Cheng CP |
Heliyon | 2022 |
|
CaMKII as a Therapeutic Target in Cardiovascular Disease
Gaido OE, Nkashama LJ, Schole KL, Wang Q, Umapathi P, Mesubi OO, Konstantinidis K, Luczak ED, Anderson ME |
Annual Review of Pharmacology and Toxicology | 2022 |
|
CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy
CR Veitch, AS Power, JR Erickson |
Frontiers in pharmacology | 2021 |
|
Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
E Dozio, L Massaccesi, MM Romanelli |
Journal of Clinical Medicine | 2021 |
|
CaMKII oxidation is a critical performance/disease trade-off acquired at the dawn of vertebrate evolution
Q Wang, EO Hernández-Ochoa, MC Viswanathan, ID Blum, DC Do, JM Granger, KR Murphy, AC Wei, S Aja, N Liu, CM Antonescu, LD Florea, CC Talbot, D Mohr, KR Wagner, S Regot, RM Lovering, P Gao, MA Bianchet, MN Wu, A Cammarato, MF Schneider, GS Bever, ME Anderson |
Nature Communications | 2021 |
|
CaMKII Serine 280 O-GlcNAcylation Links Diabetic Hyperglycemia to Proarrhythmia
B Hegyi, A Fasoli, CY Ko, BW Van, CC Alim, EY Shen, MM Ciccozzi, S Tapa, CM Ripplinger, JR Erickson, J Bossuyt, DM Bers |
Circulation research | 2021 |
|
CaMKII in Regulation of Cell Death During Myocardial Reperfusion Injury
Y Yang, K Jiang, X Liu, M Qin, Y Xiang |
Frontiers in Molecular Biosciences | 2021 |
|
Excessive O -GlcNAcylation Causes Heart Failure and Sudden Death
P Umapathi, OO Mesubi, PS Banerjee, N Abrol, Q Wang, ED Luczak, Y Wu, JM Granger, AC Wei, OE Gaido, L Florea, CC Talbot, GW Hart, NE Zachara, ME Anderson |
Circulation | 2021 |
|
Calcium Signaling Silencing in Atrial Fibrillation: Implications for Atrial Sodium Homeostasis
AD Kaplan, HC Joca, L Boyman, M Greiser |
International journal of molecular sciences | 2021 |
|
New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation
M Aguilar, RA Rose, A Takawale, S Nattel, S Reilly |
Cardiovascular Research | 2021 |
|
Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation
D Bode, L Semmler, CU Oeing, A Alogna, GG Schiattarella, BM Pieske, FR Heinzel, F Hohendanner |
International journal of molecular sciences | 2021 |
|
IRF5 inhibitor shows promise in mouse models of SLE
J McHugh |
Nature Reviews Rheumatology | 2020 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)